XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2018/07/31/biosimilar-litigation-updates-2/20%Monthly2018-08-10 19:10
https://www.bigmoleculewatch.com/2018/07/30/breaking-news-update-janssen-v-celltrion-district-court-rules-in-favor-of-celltrion-on-summary-judgment-of-non-infringement/20%Monthly2018-07-30 20:15
https://www.bigmoleculewatch.com/2018/07/30/fda-biosimilars-labeling-guidance/20%Monthly2018-08-14 16:34
https://www.bigmoleculewatch.com/2018/07/26/dr-reddys-laboratories-announces-launch-of-hervycta-trastuzumab-in-india/20%Monthly2018-07-27 18:34
https://www.bigmoleculewatch.com/2018/07/26/biocon-mylan-has-launched-fulphila-pegfilgrastim-jmdb-biosimilar-in-the-u-s/20%Monthly2018-07-27 18:35
https://www.bigmoleculewatch.com/2018/07/25/congressman-sarbanes-introduces-bill-to-curb-pay-for-delay-agreements/20%Monthly2018-07-30 15:15
https://www.bigmoleculewatch.com/2018/07/25/glenmark-reports-positive-phase-1-results-on-biosimilarity-of-gbr-310-to-omalizumab/20%Monthly2018-07-27 18:36
https://www.bigmoleculewatch.com/2018/07/23/maine-law-attempts-to-curb-rems-restrictions-for-biosimilar-applicants/20%Monthly2018-07-25 14:08
https://www.bigmoleculewatch.com/2018/07/20/fda-approval-of-nivestym/20%Monthly2018-07-20 21:06
https://www.bigmoleculewatch.com/2018/07/20/federal-circuit-rules-no-tribal-immunity-in-iprs/20%Monthly2018-09-04 13:31
https://www.bigmoleculewatch.com/2018/07/18/fda-releases-biosimilar-action-plan-bap-to-enhance-biosimilar-competition-and-market-penetration/20%Monthly2018-07-20 13:20
https://www.bigmoleculewatch.com/2018/07/18/new-bpcia-complaint-amgen-sues-pfizer-over-proposed-filgrastim-biosimilar/20%Monthly2018-10-11 15:52
https://www.bigmoleculewatch.com/2018/07/18/jj-despite-biosimilar-competition-remicade-retains-approximately-94-of-infliximab-volume-share/20%Monthly2018-07-20 13:29
https://www.bigmoleculewatch.com/2018/07/17/abbvie-licenses-humira-adalimumab-patents-to-mylan/20%Monthly2018-07-17 14:39
https://www.bigmoleculewatch.com/2018/07/13/bpcia-litigation-roundup-q2-2018/20%Monthly2018-07-20 13:25
https://www.bigmoleculewatch.com/2018/07/12/xbrane-and-stada-collaborating-to-develop-lucentis-biosimilar/20%Monthly2018-07-13 00:18
https://www.bigmoleculewatch.com/2018/07/12/jhl-biotech-to-initiate-global-phase-iii-clinical-study-of-rituximab-biosimilar-candidate/20%Monthly2018-07-13 00:17
https://www.bigmoleculewatch.com/2018/07/11/fda-to-unveil-biosimilars-action-plan-bap/20%Monthly2018-07-12 01:10
https://www.bigmoleculewatch.com/2018/07/11/insight-the-ongoing-debate-about-disclosing-manufacturing-process-information-in-the-patent-dance/20%Monthly2018-07-24 13:38
https://www.bigmoleculewatch.com/2018/07/10/biosimilar-related-appeals-pending-before-the-federal-circuit/20%Monthly2018-07-10 22:26
https://www.bigmoleculewatch.com/2018/07/10/genentech-files-patent-infringement-complaint-against-lilly-regarding-lillys-taltz-product/20%Monthly2018-07-10 16:09
https://www.bigmoleculewatch.com/2018/07/09/biocon-biosimilars-facility-receives-eu-gmp-certification/20%Monthly2018-07-13 15:35
https://www.bigmoleculewatch.com/2018/07/06/fda-releases-guidance-for-industry-regarding-implementation-of-biosimilar-user-fee-amendments-of-2017/20%Monthly2018-07-11 14:55
https://www.bigmoleculewatch.com/2018/07/05/sandoz-files-responsive-brief-in-amgen-v-sandoz-appeal/20%Monthly2018-07-09 14:51
https://www.bigmoleculewatch.com/2018/07/05/biosimilars-update-clinical-trials-marketing-authorization-applications-licenses-and-launches/20%Monthly2018-07-05 14:53
https://www.bigmoleculewatch.com/2018/07/02/senators-ask-ftc-to-examine-biosimilar-patent-settlements-for-antitrust-violations/20%Monthly2018-07-03 01:55